FEBUVIB 40 FEBUXOSTAT 40mg. IP

Febuvib 40 tablets are used for the long-term management of raised uric acid in adults with gout. Main uses: long-term management of raised uric acid levels (hyperuricemia) in adults with gout; for gout patients who get an inadequate response to a maximally titrated dose of allopurinol; for gout patients who are intolerant to allopurinol; for gout patients for whom treatment with allopurinol is not advisable.

Common side effects of Febuvib 40 Tablet include abnormal liver function test results; nausea; joint pain (arthralgia); skin rash; gout flares, which are often seen when treatment is first started. Get medical help at once if you notice liver failure has been reported in some cases, some of them fatal; serious skin and hypersensitivity reactions such as Stevens-Johnson syndrome, DRESS and toxic epidermal necrolysis; cardiovascular death, seen at a higher rate in gout patients with established cardiovascular disease.

Each Febuvib 40 tablet contains Febuxostat 40 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Febuvib 40 Tablet only as your doctor advises.

The MRP of Febuvib 40 Tablet is ₹190 for a pack of 10x15 (Alu Alu). For chemists and distributors, the PTR is ₹144.76 and the PTS is ₹130.29.

Each Febuvib 40 tablet contains Febuxostat 40 mg. It comes in a pack of 10x15 (Alu Alu).

Febuxostat works by blocking the enzyme xanthine oxidase, which the body uses to make uric acid. With less uric acid being formed, the level of uric acid in the blood falls and the deposits that trigger gout are less likely to build up over time.

Must not be used by patients being treated with azathioprine or mercaptopurine. Check with a doctor first if you have established cardiovascular disease such as heart attack, stroke or heart failure, as a higher rate of cardiovascular death was seen in these patients and the doctor should weigh the risks and benefits. Check with a doctor first if you have high uric acid with no gout symptoms (asymptomatic hyperuricemia), as febuxostat is not recommended for this. Check with a doctor first if you have liver problems; if signs of liver injury appear during treatment, treatment must be interrupted promptly and a doctor should be contacted for assessment, and febuxostat stopped if liver injury is confirmed. Check with a doctor first if you are pregnant, planning a pregnancy or breastfeeding.

Febuvib 40 Tablet is a brand of Vibcare Pharma, sold through its Prima division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.